Cover Image

Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream

Riley K Spencer,1,2 Joy Q Jin,2,3 Kareem G Elhage,2 Mitchell S Davis,2 Wilson Liao,2 Tina Bhutani2 1Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA; 2Department of Dermatology, University of California at San Francisco, San Francisco, CA, USA; 3School of Medicine, U...

Full description

Saved in:

Bibliographic Details
Main Authors:	Spencer RK (Author), Jin JQ (Author), Elhage KG (Author), Davis MS (Author), Liao W (Author), Bhutani T (Author)
Format:	Book
Published:	Dove Medical Press, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
by: Jin JQ, et al.
Published: (2023)

Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis
by: Leon Kircik, et al.
Published: (2023)

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
by: Seemal R. Desai, et al.
Published: (2023)

Tapinarof: A novel topical agent for psoriasis
by: Neethu Jaleel, et al.
Published: (2023)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017)

Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation
by: Riley K. Spencer, et al.
Published: (2023)

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
by: Mitchell S. Davis, et al.
Published: (2023)

Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
by: Reddy V, et al.
Published: (2020)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
by: Riley K. Spencer, et al.
Published: (2023)

Treatment of palmoplantar keratoderma in a patient with ichthyosis with topical tapinarof
by: Sarah N. Robinson, MD, et al.
Published: (2024)

First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report
by: Naiem T. Issa, et al.
Published: (2023)

Nonulcerated Necrobiosis Lipoidica Successfully Treated with Tapinarof: A Case Report
by: Palomares SJ, et al.
Published: (2023)

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
by: Tiago Torres, et al.
Published: (2023)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
by: Yang EJ, et al.
Published: (2019)

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
by: Lisa Liu, BS, et al.
Published: (2023)

Improvement effects of tapinarof on the skin barrier function in Japanese patients with atopic dermatitis
by: Atsuyuki Igarashi, et al.
Published: (2024)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021)

Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
by: Reddy V, et al.
Published: (2020)

Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
by: Chung M, et al.
Published: (2022)

Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database
by: Payton Smith, et al.
Published: (2024)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
by: Mahé E
Published: (2020)

Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial
by: Zafer Sezer, et al.
Published: (2023)

Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysisCapsule Summary
by: Helen Y. Sun, BSc (Med), et al.
Published: (2021)

Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp
by: Nuria García, et al.
Published: (2023)

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
by: Beck KM, et al.
Published: (2018)

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents
by: Audrey Melin, et al.
Published: (2021)

Position Statement on Secukinumab in the Management of Plaque Psoriasis: The Malaysian Perspective
by: Asmah Johar, et al.
Published: (2019)

Etanercept in the treatment of plaque psoriasis
by: Thao U Nguyen, et al.
Published: (2009)

Psoriasis and Exercise: A Review
by: Yeroushalmi S, et al.
Published: (2022)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
by: Gao JC, et al.
Published: (2022)

Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
by: Tina Bhutani, et al.
Published: (2024)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
by: Ruggiero A, et al.
Published: (2023)

Transcriptomic Profiling of Plaque Psoriasis and Cutaneous T-Cell Subsets during Treatment with Secukinumab
by: Jared Liu, et al.
Published: (2022)

Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features
by: Karen Regina Rosso Schons, et al.
Published: (2015)

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017)

Infliximab in the treatment of plaque type psoriasis
by: Rosita Saraceno, et al.
Published: (2009)

The significance of secukinumab in the treatment of plaque psoriasis
by: Marta Kasprowicz-Furmańczyk, et al.
Published: (2022)

Bacterial colonization of psoriasis plaques. Is it relevant?
by: Eva Marcus, et al.
Published: (2011)

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France - the POP study
by: A. P. Villani, et al.
Published: (2023)